Sign inJoin waitlistJoin the waitlist

Davood Vafai

Board Certified Medical Oncologist · Eisenhower Medical Center

Credentials: · · ·

History

Eisenhower Medical Center
Present

Hematology and Medical Oncology
University of California (San Diego) Medical Center
1987–1990
Los Angeles County Univ. of So. Cal Medical Center
1985–1987
Los Angeles County Univ. of So. Cal Medical Center
1982–1985
Englewood Hospital Medical Center
1981–1982
Tehran Medical School
1977–1981

Research

Emergence of FGFR3-TACC3 fusions as a potential by-pass resistance mechanism to EGFR tyrosine kinase inhibitors in EGFR mutated NSCLC patients
Lung Cancer · 2017 · 55 citations
Paclitaxel 3-hour infusion given alone and combined with carboplatin: preliminary results of dose-escalation trials
Seminars in Oncology · 1995 · 32 citations
Genomic Profiling of Circulating Tumor DNA in Relapsed EGFR-mutated Lung Adenocarcinoma Reveals an Acquired FGFR3-TACC3 Fusion
Case report · Clinical Lung Cancer · 2017 · Last of 9 authors · 13 citations

SO
Sai-Hong I Ou
2 papers
SA
Siraj Ali
2 papers
VM
Vincent Miller
2 papers
Christine Lovly
1 paper
FM
Franco Muggia
1 paper
ID
Ibiayi Dagogo-Jack
1 paper · 1 as a fellow
Jeffrey Ross
1 paper
LH
Leora Horn
1 paper
MC
Marcelo Cruz
1 paper · 1 as a resident
MW
Michael Williamson
1 paper
RN
Ronald Natale
1 paper
Shirish Gadgeel
1 paper

Clinical trials

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
Site PI · Recruiting · Phase 2
SWOG Cancer Research Network
2025–2029
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Site PI · Recruiting · Phase 2, Phase 3
SWOG Cancer Research Network
2025–2028